VelosBio
Merck & Co., Inc. is a research-intensive biopharmaceutical company dedicated to discovering, developing, and delivering innovative health solutions including medicines, vaccines, biologic therapies, and animal health products. With a history spanning over 130 years, the company aims to use leading-edge science to save and improve lives worldwide, operating responsibly to ensure a safe, sustainable, and healthy future for all communities.
Industries
Nr. of Employees
small (1-50)
VelosBio
San Diego, California, United States, North America
Products
Vaccines (portfolio of viral, conjugate and multivalent vaccines)
Commercial vaccine products and investigational vaccine candidates across multiple indications and age groups.
Therapeutic medicines (small molecules and biologics)
Commercial and pipeline therapeutic agents for oncology, cardio-metabolic disorders, infectious diseases and other therapeutic areas.
Animal health pharmaceuticals, vaccines and connected solutions
Veterinary pharmaceuticals and vaccines combined with connected identification, traceability and monitoring technologies for livestock and companion animals.
Vaccines (portfolio of viral, conjugate and multivalent vaccines)
Commercial vaccine products and investigational vaccine candidates across multiple indications and age groups.
Therapeutic medicines (small molecules and biologics)
Commercial and pipeline therapeutic agents for oncology, cardio-metabolic disorders, infectious diseases and other therapeutic areas.
Animal health pharmaceuticals, vaccines and connected solutions
Veterinary pharmaceuticals and vaccines combined with connected identification, traceability and monitoring technologies for livestock and companion animals.
Services
Business development and licensing
Evaluation and management of external collaborations, licensing deals and partnership integration to advance pipeline assets.
Clinical trial operations and support
Operational support for clinical trials including trial design, patient recruitment, diversity initiatives and trial management.
Patient support programs and adverse event reporting
Patient financial assistance programs and 24/7 adverse event/product-quality reporting channels.
Responsible vulnerability disclosure and security reporting
Channel for security researchers to report potential vulnerabilities in digital products, with defined scope and reporting procedures.
Business development and licensing
Evaluation and management of external collaborations, licensing deals and partnership integration to advance pipeline assets.
Clinical trial operations and support
Operational support for clinical trials including trial design, patient recruitment, diversity initiatives and trial management.
Patient support programs and adverse event reporting
Patient financial assistance programs and 24/7 adverse event/product-quality reporting channels.
Responsible vulnerability disclosure and security reporting
Channel for security researchers to report potential vulnerabilities in digital products, with defined scope and reporting procedures.
Expertise Areas
- Clinical trial management
- Vaccine development and manufacturing
- Oncology research (including ADCs)
- Infectious disease research
Key Technologies
- Data science and artificial intelligence
- Generative AI applied to R&D workflows
- Vaccine platforms
- Antibody-drug conjugates